Announcements Trials
Browse Landscape

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 46Observational 1

Sponsor

Cancer Type

Gastrointestinal 18Breast 18Thoracic 13Genitourinary 11Other hematologic neoplasm 7Dermatologic 7Tumor-Agnostic 5Gynecologic 5Sarcoma 3Plasma cell 3Other solid neoplasm 2CNS 2Lymphoid 1Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Papillomavirus Infections 1

Interventions

Surveys and Questionnaires 40Blood Specimen Collection 30Radiotherapy 20Immunohistochemistry 13Gene Expression Profiling 12Radiotherapy, Intensity-Modulated 11Cisplatin 11Surgical Procedures, Operative 10Biopsy 10Drug Therapy 9Cetuximab 9Ultrasonography 8Thyroidectomy 8Observation 8Transurethral Resection of Prostate 7Nivolumab 7Interviews as Topic 7pembrolizumab 6Therapeutics 6Radiation 6Polymerase Chain Reaction 6Immunotherapy 6Biopsy, Fine-Needle 6Positron Emission Tomography Computed Tomography 5Microarray Analysis 5Liquid Biopsy 5Iodine-131 5Docetaxel 5Chemoradiotherapy 5Tissue Banks 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Specimen Handling × Head & Neck × Clear all
NCT06362421 2025-07-31

Saliva Testing for High-Risk Human Papillomavirus Infection Oral Cavity and Pharynx Cancer

Wake Forest University Health Sciences

Withdrawn
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡